- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
- Bio-Rad Announces Life Science Group Management Changes
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
More ▼
Key statistics
On Friday, Bio Rad Laboratories Inc (BIO:NYQ) closed at 279.83, 6.97% above its 52-week low of 261.59, set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 280.75 |
---|---|
High | 283.50 |
Low | 279.57 |
Bid | 265.80 |
Offer | 307.53 |
Previous close | 279.31 |
Average volume | 229.94k |
---|---|
Shares outstanding | 33.61m |
Free float | 25.07m |
P/E (TTM) | -- |
Market cap | 9.41bn USD |
EPS (TTM) | -21.49 USD |
Data delayed at least 15 minutes, as of May 03 2024 21:10 BST.
More ▼